Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Active, Not Recruiting

Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

NCT03334617

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

NCT03401385

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +15 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

NCT04194944

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centro de Oncología e Investigación de Buenos Aires Berazategui, Buenos Aires, Argentina
  • Fundacion CENIT para la Investigacion en Neurociencias Caba, Buenos Aires, Argentina
  • Clinica Viedma Viedma, Río Negro Province, Argentina
  • Alexander Fleming Ciudad de Buenos Aires, Argentina
View all 196 locations
View Trial Details
Active, Not Recruiting

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

NCT00977470

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Maryland Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

NCT02767804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

NCT04035486

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Bellflower, California, United States
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Santa Monica, California, United States
View all 153 locations
View Trial Details
Active, Not Recruiting

SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.

NCT05020769

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangdong, Guangzhou, China
View Trial Details
Active, Not Recruiting

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

NCT03289780

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncology Specialties, PC; Clearview Cancer Institute Huntsville, Alabama, United States
  • Lewis & Faye Manderson Cancer Center at DCH Regional Medical Center Tuscaloosa, Alabama, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Bernards Cancer Center Hematology / Oncology Jonesboro, Arkansas, United States
View all 42 locations
View Trial Details

Related conditions